Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
648.00    3.50 (0.54%)
Bid:
648.50
Ask:
650.50
Spread: 2.00 (0.308%)
Market Cap: £1.10b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Trading Update

15 Nov 2018 07:00

RNS Number : 4066H
Bodycote PLC
15 November 2018
 

15 November 2018

Bodycote plc

Trading Update

 

Bodycote, the world's leading provider of heat treatment and specialist thermal processing services, is issuing this trading update covering the four month period from 1 July to 31 October 2018 ("the period").

 

Current trading

Group revenue for the period was £243.5m, 5% higher than the comparative period last year and 6% higher at constant currency, and in line with our expectations. This represents solid growth, particularly given the strong performance in the comparative period in 2017. Group revenue for the 10 months to 31 October 2018 grew 6% (8% at constant currency), with Specialist Technologies continuing its strong growth, up 11% at constant currency (both in the period and year-to-date).

 

All percentage movements in the following review of the Group's markets compare to the same period in 2017, at constant currency.

 

Car and light truck revenues grew 5%, notwithstanding weak background market demand in Europe and North America. The growth has been driven by continued strong performance in Emerging Markets and Specialist Technologies.

 

Civil aerospace revenues grew strongly at 14%, with North America and Western Europe both registering good growth. This reflects increasing output for the LEAP program and an easing in the OEM supply chain bottlenecks for Titanium castings.

 

Energy revenues grew 4%, as the Oil & Gas business continues to perform well, while our Industrial Gas Turbines (IGT) business weakened further with underlying revenues falling by more than 25% in the period.

 

General industrial revenues were 4% higher, in line with the general trends in industrial production.

 

On a divisional basis, ADE revenues were up 6% to £97.8m (up 6% at constant currency, and for the 10 months to 31 October 2018, 8% ahead), while AGI revenues were up 5% to £145.7m (up 6% at constant currency, and for the 10 months to 31 October 2018, up 8%).

 

Financial position

Net cash as at 31 October 2018 was £16.0m compared to net cash of £17.7m at 30 June 2018. During the period, we continued to invest in our network of new and existing facilities, including a small acquisition in North America, as well as a £9m purchase of shares for our Employee Share Benefit Scheme. Underlying cash generation remains strong. The interim dividend of 5.7p per share was paid on 2 November 2018, at a cost of £10.1m.

 

Summary and outlook

As anticipated, the pace of revenue growth will moderate in the last two months given the strong prior year comparator. Bodycote's outlook for 2018 remains unchanged.

 

- END -

 

Trading Update Conference Call

Stephen Harris and Dominique Yates will be hosting a conference call for analysts and investors at 8.00am today (Thursday 15 November 2018).

 

Participant's dial in number : +443333009260 (Direct)Participants will be asked for names only, no PIN required

 

For further information, please contact:

Bodycote plc

Stephen Harris, Group Chief ExecutiveDominique Yates, Chief Financial OfficerFiona Lawrence, Head of Investor RelationsTel No +44(0) 1625 505300

 

FTI Consulting

Richard Mountain

Susanne Yule

Tel No +44 (0) 203727134

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDGBDBIGBBGIS
Date   Source Headline
21st Mar 20192:40 pmPRNDirector/PDMR Shareholding
8th Mar 20197:00 amRNSFull Year Results to 31 December 2018
28th Feb 20195:00 pmPRNTotal Voting Rights
14th Feb 20193:44 pmPRNHolding(s) in Company
12th Feb 20194:21 pmPRNHolding(s) in Company
31st Jan 20195:00 pmPRNTotal Voting Rights
4th Jan 20195:25 pmPRNTotal Voting Rights
18th Dec 20184:50 pmRNSHolding(s) in Company
30th Nov 20185:00 pmPRNTotal Voting Rights
15th Nov 20187:00 amRNSTrading Update
5th Nov 20181:03 pmPRNExternal Board Appointment
31st Oct 20185:00 pmPRNTotal Voting Rights
29th Oct 20184:09 pmRNSHolding(s) in Company
18th Oct 20189:30 amPRNHolding(s) in Company
11th Oct 20184:42 pmPRNDirector/PDMR Shareholding
28th Sep 20184:30 pmPRNTotal Voting Rights
18th Sep 20182:07 pmRNSHolding(s) in Company
7th Sep 20183:10 pmPRNDirector/PDMR Shareholding
31st Aug 20185:00 pmPRNTotal Voting Rights
16th Aug 201810:42 amPRNHolding(s) in Company
13th Aug 201810:27 amRNSHolding(s) in Company
31st Jul 20185:00 pmPRNTotal Voting Rights
27th Jul 20185:11 pmPRNHolding(s) in Company
26th Jul 20187:00 amRNSResults for the six months to 30 June 2018
17th Jul 20187:00 amRNSBODYCOTE TO OPEN NEW HEAT TREATMENT FACILITY IN UK
9th Jul 20185:07 pmRNSHolding(s) in Company
3rd Jul 201810:02 amPRNHolding(s) in Company
3rd Jul 20189:36 amPRNHolding(s) in Company
29th Jun 20185:00 pmPRNTotal Voting Rights
7th Jun 20184:49 pmPRNDirector/PDMR Shareholding
31st May 20185:00 pmPRNTotal Voting Rights
30th May 20181:10 pmRNSResult of AGM
30th May 20187:00 amRNSTrading Update
22nd May 20185:10 pmPRNChange in Director's Particulars
21st May 201812:49 pmPRNHolding(s) in Company
17th May 201812:36 pmPRNHolding(s) in Company
14th May 20184:53 pmPRNHolding(s) in Company
23rd Apr 20185:41 pmPRNDirector/PDMR Shareholding
23rd Apr 20182:50 pmPRNGrant of deferred bonus share award
18th Apr 20182:00 pmPRNChanges in Director's Particulars
18th Apr 20187:00 amRNS15-year contract with Rolls-Royce
12th Apr 201811:33 amPRNDirector/PDMR Shareholding
29th Mar 20186:00 pmPRNTotal Voting Rights
29th Mar 20189:00 amPRNAnnual Financial Report
7th Mar 201812:11 pmPRNChanges in Director's Particulars
6th Mar 201811:47 amPRNDirector/PDMR Shareholding
6th Mar 20187:00 amRNSFinal Results
28th Feb 20185:00 pmPRNTotal Voting Rights
20th Feb 20187:00 amRNSBODYCOTE ENTERS INTO AGREEMENT WITH SAFRAN
12th Feb 20185:30 pmPRNChanges in Director's Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.